ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #17,941Hybrid

Bulletin Du Cancer

Acronym:bulcan
•
Abbreviation (ISO):B CANCER
•
Identifier (ISSN):0007-4551(Print)/1769-6917(Online)
•
Publisher:John Libbey Eurotext
Clarivate IF (2026)
1.1↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Bulletin Du Cancer

WoS Q4
01120.8420180.7320190.9120201.2820211.3220221.220231.120240.820251.12026
Annual Impact Factor Metric
Current (2026):1.1
Scopus SJR & RankScopus Q3
0.28
#17,941

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
46

46 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate18.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
146articles/year
20.95% Gold OA•92.42% Original Research

Aims & Scope

Without doubt, the 'Bulletin du Cancer' is the French language publication of reference in the field of cancerology. Official organ of the French Society of Cancer, this journal covers all the information available, whether in the form of original articles or review articles, but also clinical cases and letters to the editor, including various disciplines as onco-hematology, solids tumors, medical oncology, pharmacology, epidemiology, biology as well as fundamental research in cancerology. The journal proposes a clinical and therapeutic approach of high scientific standard and regular updates in knowledge are thus made possible. Articles can be submitted in French or English.

Topics Covered (Recognized by AI)
Medicine91%Biology71.9%Internal medicine62.7%Genetics59.7%Cancer42.5%Pathology35.1%Surgery32.7%Chemistry29.5%Oncology24.6%Biochemistry23.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q4
Rank299/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q4
Rank303/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.1
Articles / Year172
Total Citations8
2025
IF0.8
Articles / Year267
Total Citations111
2024
IF1.1
Articles / Year221
Total Citations176
2023
IF1.2
Articles / Year237
Total Citations420
2022
IF1.318
Articles / Year242
Total Citations599

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,941Scopus Q3SCImago Profile
Scopus Coverage:1966-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.28

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.78

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,678 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations453
3-Year Documents536
Citable Documents372

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate56.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q3
Radiology, Nuclear Medicine and ImagingQ3
Cancer ResearchQ4
HematologyQ4
OncologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 18.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Bulletin Du Cancer (acronym: bulcan, abbr: B CANCER, ISSN: 0007-4551) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Libbey Eurotext in France since 1966. The periodical holds a Journal Impact Factor (JIF) of 1.10, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.280 (Q3), an H-index of 46.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 146 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,678 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Libbey Eurotext
Publication Language
French
Frequency
Monthly
Founding Year
1966
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN LIBBEY EUROTEXT LTD, 127 AVE DE LA REPUBLIQUE, MONTROUGE, FRANCE, 92120

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ba76cb53-c908-4ddd-b08b-56821b266926
Database Updated: 2026-10-16